383 related articles for article (PubMed ID: 25645235)
1. [Pre-interventional, peri-interventional and post-interventional anticoagulation in the setting of catheter ablation for atrial fibrillation : current practice and practical approach].
Antz M; Willems S; Hoffmann BA
Herz; 2015 Feb; 40(1):45-9. PubMed ID: 25645235
[TBL] [Abstract][Full Text] [Related]
2. Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation.
Efremidis M; Vlachos K; Letsas KP; Giannopoulos G; Lioni L; Georgopoulos S; Vadiaka M; Deftereos S; Sideris A
J Electrocardiol; 2015; 48(5):840-4. PubMed ID: 26152604
[TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulant use around the time of atrial fibrillation ablation: a review of the current evidence of individual oral anticoagulant use for periprocedural atrial fibrillation ablation thromboembolic prophylaxis.
Garton AB; Dudzinski J; Kowey PR
J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1411-8. PubMed ID: 25216104
[TBL] [Abstract][Full Text] [Related]
4. Peri-procedural Anticoagulation in Catheter Ablation for Atrial Fibrillation: A Review.
Vrachatis DA; Giannopoulos G; Kossyvakis C; Panagopoulou V; Vavuranakis M; Papaioannou TG; Pagoni S; Pyrgakis VN; Cleman MW; Deftereos SG
Curr Pharm Des; 2017; 23(9):1334-1345. PubMed ID: 27917710
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of dabigatran versus warfarin for periablation anticoagulation in patients undergoing ablation of atrial fibrillation.
Nin T; Sairaku A; Yoshida Y; Kamiya H; Tatematsu Y; Nanasato M; Inden Y; Hirayama H; Murohara T
Pacing Clin Electrophysiol; 2013 Feb; 36(2):172-9. PubMed ID: 23121681
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
[TBL] [Abstract][Full Text] [Related]
7. Cardiac implantable electronic device lead-based masses and atrial fibrillation ablation: a case-based illustration of periprocedural anticoagulation management strategies.
Lenz CJ; DeSimone CV; Ponamgi SP; Sugrue A; Sinak LJ; Chandrasekaran K; Packer DL; Asirvatham SJ
J Interv Card Electrophysiol; 2016 Sep; 46(3):237-43. PubMed ID: 26898212
[TBL] [Abstract][Full Text] [Related]
8. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.
Providência R; Marijon E; Albenque JP; Combes S; Combes N; Jourda F; Hireche H; Morais J; Boveda S
Europace; 2014 Aug; 16(8):1137-44. PubMed ID: 24550347
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulants before and after ablation for atrial fibrillation.
Verheugt FW; Khan M; De Ruiter GS; Riezebos RK
Europace; 2010 Jul; 12(7):913-4. PubMed ID: 20530641
[No Abstract] [Full Text] [Related]
10. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
[TBL] [Abstract][Full Text] [Related]
11. Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis.
Ha FJ; Barra S; Brown AJ; Begley DA; Grace AA; Agarwal S
Int J Cardiol; 2018 Jul; 262():51-56. PubMed ID: 29606512
[TBL] [Abstract][Full Text] [Related]
12. [New Oral Anticoagulants During Catheter Ablation of Atrial Fibrillation. Experience With Rivaroxaban].
Kazakov AI; Yashin SM; Lyan EV; Ayrapetyan AV
Kardiologiia; 2015; 55(8):30-4. PubMed ID: 26761969
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation.
Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Komatsubara I; Kusachi S
J Cardiovasc Pharmacol; 2017 Feb; 69(2):118-126. PubMed ID: 28170360
[TBL] [Abstract][Full Text] [Related]
14. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation.
Nagao T; Inden Y; Yanagisawa S; Kato H; Ishikawa S; Okumura S; Mizutani Y; Ito T; Yamamoto T; Yoshida N; Hirai M; Murohara T
Heart Rhythm; 2015 Sep; 12(9):1972-8. PubMed ID: 25881495
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation.
Phan K; Wang N; Pison L; Kumar N; Hitos K; Thomas SP
Int J Cardiol; 2015 Jun; 189():199-203. PubMed ID: 25897906
[No Abstract] [Full Text] [Related]
16. Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon.
Kaess BM; Ammar S; Reents T; Dillier R; Lennerz C; Semmler V; Grebmer C; Bourier F; Buiatti A; Kolb C; Deisenhofer I; Hessling G
Am J Cardiol; 2015 Jan; 115(1):47-51. PubMed ID: 25456870
[TBL] [Abstract][Full Text] [Related]
17. Safety of atrial fibrillation ablation with novel multi-electrode array catheters on uninterrupted anticoagulation-a single-center experience.
Hayes CR; Keane D
J Interv Card Electrophysiol; 2010 Mar; 27(2):117-22. PubMed ID: 20082132
[TBL] [Abstract][Full Text] [Related]
18. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment.
Hakalahti A; Uusimaa P; Ylitalo K; Raatikainen MJ
Europace; 2011 May; 13(5):640-5. PubMed ID: 21398311
[TBL] [Abstract][Full Text] [Related]
19. Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation.
Eitel C; Koch J; Sommer P; John S; Kircher S; Bollmann A; Arya A; Piorkowski C; Hindricks G
Europace; 2013 Nov; 15(11):1587-93. PubMed ID: 23703362
[TBL] [Abstract][Full Text] [Related]
20. Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation.
Gjermeni D; Saglam NP; Olivier CB; Kühlkamp V
Eur Heart J Open; 2023 Jul; 3(4):oead065. PubMed ID: 37427356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
